HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.

Direct download: 067_-_DM2017_Part2.mp3
Category:general -- posted at: 6:00am EST

In this episode, we discuss updates in diabetes management that includes nuances from the ADA’s Standards of Care 2017. We also review some newer pharmacologic agents, a fixed dose GLP-1 agonist and basal insulin combinations.

Direct download: 066_-_DM2017_Part1.mp3
Category:general -- posted at: 6:00am EST

1